Petrović N - Search Results

1

Breast Cancer Response to Therapy: Can microRNAs Lead the Way?

Petrović N, Nakashidze I, Nedeljković M. Petrović N, et al. J Mammary Gland Biol Neoplasia. 2021 Jun;26(2):157-178. doi: 10.1007/s10911-021-09478-3. Epub 2021 Jan 21. J Mammary Gland Biol Neoplasia. 2021. PMID: 33479880 Review.

2

The difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion.

Petrović N, Mandušić V, Stanojević B, Lukić S, Todorović L, Roganović J, Dimitrijević B. Petrović N, et al. Med Oncol. 2014 Mar;31(3):867. doi: 10.1007/s12032-014-0867-x. Epub 2014 Feb 2. Med Oncol. 2014. PMID: 24488617

3

MiR-155 expression level changes might be associated with initial phases of breast cancer pathogenesis and lymph-node metastasis.

Petrović N, Kolaković A, Stanković A, Lukić S, Řami A, Ivković M, Mandušić V. Petrović N, et al. Cancer Biomark. 2016;16(3):385-94. doi: 10.3233/CBM-160577. Cancer Biomark. 2016. PMID: 26889816

4

miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development.

Petrović N. Petrović N. Mol Diagn Ther. 2016 Apr;20(2):97-110. doi: 10.1007/s40291-016-0186-3. Mol Diagn Ther. 2016. PMID: 26891730 Review.

5

Changes in miR-221/222 Levels in Invasive and In Situ Carcinomas of the Breast: Differences in Association with Estrogen Receptor and TIMP3 Expression Levels.

Petrovic N, Davidovic R, Jovanovic-Cupic S, Krajnovic M, Lukic S, Petrovic M, Roganovic J. Petrovic N, et al. Among authors: petrovic m. Mol Diagn Ther. 2016 Dec;20(6):603-615. doi: 10.1007/s40291-016-0230-3. Mol Diagn Ther. 2016. PMID: 27488105

6

Levels of MicroRNA Heterogeneity in Cancer Biology.

Petrovic N, Ergün S, Isenovic ER. Petrovic N, et al. Mol Diagn Ther. 2017 Oct;21(5):511-523. doi: 10.1007/s40291-017-0285-9. Mol Diagn Ther. 2017. PMID: 28620889 Review.

7

TIMP-3 mRNA expression levels positively correlates with levels of miR-21 in in situ BC and negatively in PR positive invasive BC.

Petrovic N, Sami A, Martinovic J, Zaric M, Nakashidze I, Lukic S, Jovanovic-Cupic S. Petrovic N, et al. Pathol Res Pract. 2017 Oct;213(10):1264-1270. doi: 10.1016/j.prp.2017.08.012. Epub 2017 Sep 6. Pathol Res Pract. 2017. PMID: 28935174

8

miRNAs as Potential Treatment Targets and Treatment Options in Cancer.

Petrovic N, Ergun S. Petrovic N, et al. Mol Diagn Ther. 2018 Apr;22(2):157-168. doi: 10.1007/s40291-017-0314-8. Mol Diagn Ther. 2018. PMID: 29335927 Review.

9

Correction to: Breast Cancer Response to Therapy: Can microRNAs Lead the Way?

Petrović N, Nakashidze I, Nedeljković M. Petrović N, et al. J Mammary Gland Biol Neoplasia. 2021 Jun;26(2):179. doi: 10.1007/s10911-021-09480-9. J Mammary Gland Biol Neoplasia. 2021. PMID: 33590361 No abstract available.

10

MicroRNAs in Prostate Cancer Following Radiotherapy: Towards Predicting Response to Radiation Treatment.

Petrović N, Stanojković TP, Nikitović M. Petrović N, et al. Curr Med Chem. 2022;29(9):1543-1560. doi: 10.2174/0929867328666210804085135. Curr Med Chem. 2022. PMID: 34348602 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

284 results

Search Page